Human Immunology News Volume 11.24 | Jun 20 2023

    0
    15








    2023-06-20 | HIN 11.24


    Human Immunology News by STEMCELL Technologies
    Vol. 11.24 – 20 June, 2023
    TOP STORY

    Intratumoral Dendritic Cell–CD4+ T Helper Cell Niches Enable CD8+ T Cell Differentiation Following PD-1 Blockade in Hepatocellular Carcinoma

    Scientists leveraged a neoadjuvant anti-PD-1 trial in patients with hepatocellular carcinoma, as well as additional samples collected from patients treated off-label, to explore correlates of response to immune checkpoint blockade within T cell-rich tumors.
    [Nature Medicine]

    AbstractPress Release
    Breakthroughs take time. Isolating the right cells shouldn't. Learn more.
    PUBLICATIONSRanked by the impact factor of the journal

    The CD58-CD2 Axis Is Co-Regulated with PD-L1 via CMTM6 and Shapes Anti-Tumor Immunity

    Investigators found that intact cancer cell-intrinsic expression of CD58 and ligation to CD2 was required for anti-tumor immunity and was predictive of treatment response.
    [Cancer Cell]

    AbstractGraphical Abstract

    Structural Insights into Siglec-15 Reveal Glycosylation Dependency for Its Interaction with T Cells through Integrin CD11b

    Researchers elucidated the crystal structure of Sialic acid-binding Ig-like lectin 15 (Siglec-15) and its binding epitope via co-crystallization with an anti-Siglec-15 blocking antibody.
    [Nature Communications]

    Full ArticlePress Release

    Identification of a Humanized Mouse Model for Functional Testing of Immune-Mediated Biomaterial Foreign Body Response

    Human innate immune macrophages were verified as essential to biomaterial rejection in the humanized mouse model and were capable of cross-talk with mouse fibroblasts for collagen matrix deposition.
    [Science Advances]

    Full Article

    Antimyeloperoxidase Antibodies Modulate Inflammatory Responses and Activate Profibrotic Pathways in Human Monocytes

    The authors investigated the effect of both antimyeloperoxidase and antiproteinase 3 IgG on human monocytes.
    [Journal of Autoimmunity]

    Abstract

    Mixtures of Per- and Poly-Fluoroalkyl Substances (PFAS) Reduce the In Vitro Activation of Human T Cells and Basophils

    Scientists investigated the effect of PFAS, short-chain, long-chain, and a mixture of both, on the in vitro activation of primary human immune cells.
    [Chemosphere]

    AbstractGraphical Abstract

    Bispecific Antibody Targeting Both B7-H3 and PD-L1 Exhibits Superior Antitumor Activities

    Researchers generated a stable B7-H3×PD-L1 bispecific antibody in IgG1-VHH format by coupling a humanized IgG1 monoclonal antibody against PD-L1 with a humanized camelus variable domain of the heavy-chain of heavy-chain antibody (VHH) against human B7-H3.
    [Acta Pharmacologica Sinica]

    Abstract

    Diversity of B Cell Populations and Ig Repertoire in Human Lungs

    The authors compared B cell subsets in human lungs versus circulating cells by analyzing patient-paired lung and blood samples.
    [Journal of Immunology]

    Abstract

    FC-Competent Multispecific PDL-1/TIGIT/LAG-3 Antibodies Potentiate Superior Anti-Tumor T Cell Response

    Scientists reported the development of a PDL1 × TIGIT bi-specific antibody GB265, a PDL1 × LAG3 bsAb GB266, and a PDL1 × TIGIT × LAG3 tri-specific antibody GB266T, all with intact Fc function.
    [Scientific Reports]

    Full Article
    Watch the webinar where Dr. Suzan Imren discusses factors affecting the balance between HSC self-renewal and leukemic transformation
    REVIEWS

    T Cells in Health and Disease

    Investigators summarize the current understanding of T cell development, CD4+ and CD8+ T cell classification, and differentiation in physiological settings.
    [Signal Transduction and Targeted Therapy]

    Full Article

    Reshaping of the Tumor Microenvironment by Cellular Senescence: An Opportunity for Senotherapies

    Scientists discuss the different types of senescent cells present in the tumor microenvironment (TME) and how these senescent cells and their senescence-associated secretory phenotype reshape the TME, affect immune responses, and influence cancer progression.
    [Developmental Cell]

    AbstractGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Immutep Granted United States Patent for IMP761, a First-in-Class Agonist Antibody Targeting LAG-3

    Immutep Limited, a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, announced the grant of a new patent by the US Patent Office.
    [Immutep Limited]

    Press Release

    Funding for Immune System Research on Transplant Responses

    A Group Leader in the Monash Biomedicine Discovery Institute, Dr. Mifsud has been awarded funding of $130,000 from the Lungitude Foundation for research into immune system function in transplants.
    [Monash University]

    Press Release

    Two UCSF Researchers Win Pew Awards for Biomedical Science

    Two University of California San Francisco (UCSF) scientists have received Pew awards in the biomedical sciences for their work in immunology as part of a program that supports promising early-career investigators.
    [The University of California San Francisco]

    Press Release
    FEATURED EVENT

    Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment

    August 28 – 30, 2023
    Santa Fe, New Mexico, United States

    > See All Events

    JOB OPPORTUNITIES

    Group Leader – Cancer Immunology

    VIB Center for Cancer Biology – Leuven, Belgium

    Research Associate – Innate Lymphoid Cells

    King’s College London – London, England, United Kingdom

    Research Assistant – Molecular Neurobiology

    Karolinska Institutet – Solna, Sweden

    Postdoctoral Fellow – Virology

    University of Pittsburgh – Pittsburgh, Pennsylvania, United States

    Postdoctoral Fellow – Cell-Based Immuno-Oncology Drug Development

    Centre for Oncology and Immunology – Hong Kong, Hong Kong

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Human Immunology News Twitter